Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCGH.L Regulatory News (CGH)

  • There is currently no data for CGH

Move to SETSqx

8 Nov 2023 07:00

RNS Number : 6400S
Chaarat Gold Holdings Ltd
08 November 2023
 

8 November 2023

Chaarat Gold Holdings Limited

("Chaarat" or the "Company")

Move to SETSqx

 

Chaarat Gold (AIM: CGH), the AIM-quoted gold mining company with assets at various stages of development in the Kyrgyz Republic, announces changes to the platform on which its shares are traded. With effect from 8 November 2023, trading in the Company's ordinary US$0.01 shares will move to the London Stock Exchange's Stock Exchange Electronic Trading Service - quotes and crosses ("SETSqx"). ISIN and SEDOL codes remain unchanged.

SETSqx is a hybrid trading system, combining features from SEAQ and SETS, and is designed for securities with reasonable levels of liquidity, but which may at times require market maker quotes to maintain levels of trading. As such, the electronic order book is split into a quote book and an order book - the quote book being the listing of quotes by appointed market makers, and the order book being electronic orders entered as they are on SETS.

Launched in 2007, market makers provide continuous liquidity throughout the trading day on the SETSqx system, whilst order book execution takes place through auctions, with four uncrossings designed to concentrate liquidity. Both market makers and non-market makers can participate in these auctions. In essence, SETSqx provides investors the opportunity to trade against market maker quotes, as well as by submitting orders into the auctions.

 

 

For further information visit www.chaarat.com or please contact:

 

Chaarat Gold Holdings Limited

+44 (0)20 7499 2612

Martin Andersson (Executive Chair)

IR@chaarat.com

 

 

Strand Hanson Limited (Nominated Adviser)

+44 (0)20 7409 3494

Ritchie Balmer / James Spinney / Robert Collins

 

 

Axis Capital Markets Limited (Joint Broker)

+44 (0)20 3026 0449

Ben Tadd / Lewis Jones

 

 

 

Panmure Gordon (UK) Limited (Joint Broker)

+44 (0)20 7886 2500

John Prior / Hugh Rich

 

 

About Chaarat

Chaarat is an exploration and development company which owns the Tulkubash and Kyzyltash Gold Projects in the Kyrgyz Republic. The Company has a clear strategy to build a leading emerging markets gold company through organic growth and selective M&A.

 

Chaarat aims to create value for its shareholders, employees and communities from its high-quality gold and mineral deposits by building relationships based on trust and operating to the best environmental, social and employment standards.

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFEALRLDIIV
Date   Source Headline
6th Jun 201711:28 amRNSDirector/PDMR Shareholding
5th Jun 20177:00 amRNSDirector/PDMR Shareholding
1st Jun 20177:00 amRNSPreliminary Results
31st May 201710:46 amRNSKyrgyz Investment Forum
16th May 20177:00 amRNSKyrgyz Investment Forum
2nd May 20177:00 amRNSDirector/PDMR Shareholding
28th Apr 20178:48 amRNSDirector/PDMR Shareholding
27th Apr 20177:01 amRNSDirector/PDMR Shareholding
27th Apr 20177:00 amRNSIssue of US$15 million short term SSCLN
24th Apr 20177:00 amRNSDirector/PDMR Shareholding
20th Apr 20178:19 amRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSDirector/PDMR Shareholding
13th Apr 201712:16 pmRNSDirector/PDMR Shareholding
12th Apr 20177:05 amRNSFurther re: Issue of US$15m short term SSCLNs
12th Apr 20177:00 amRNSIssue of US$15m short term senior secured CLNs
3rd Apr 20177:00 amRNSTulkubash Heap Leach Project - 1st Stage Financing
27th Mar 20178:12 amRNSHolding(s) in Company
17th Mar 20175:08 pmRNSHolding(s) in Company
17th Mar 20175:06 pmRNSHolding(s) in Company
24th Feb 20179:31 amRNSHolding(s) in Company
24th Feb 20179:28 amRNSDirector/PDMR Shareholding
22nd Feb 20173:10 pmRNSDirector/PDMR Shareholding
22nd Feb 20177:00 amRNSDirector/PDMR Shareholding
21st Feb 20174:25 pmRNSHolding(s) in Company
21st Feb 20172:56 pmRNSDirector/PDMR Shareholding
20th Feb 20174:40 pmRNSSecond Price Monitoring Extn
20th Feb 20174:35 pmRNSPrice Monitoring Extension
17th Feb 20176:24 pmRNSREPLACEMENT - Director/PDMR Shareholding
17th Feb 20174:24 pmRNSDirector/PDMR Shareholding
17th Feb 20177:00 amRNSDirector/PDMR Shareholding
16th Feb 20174:52 pmRNSDirector/PDMR Shareholding
16th Feb 20174:40 pmRNSSecond Price Monitoring Extn
16th Feb 20174:35 pmRNSPrice Monitoring Extension
15th Feb 20179:28 amRNSDirector/PDMR Shareholding
14th Feb 20172:10 pmRNSGRANT OF OPTIONS TO DIRECTORS AND PDMR
13th Feb 20177:00 amRNSUpdate on the Tulkubash Project & COO appointment
7th Feb 20174:48 pmRNSDirector/PDMR Shareholding
6th Feb 20178:45 amRNSDirector/PDMR Shareholding
2nd Feb 20176:20 pmRNSDirector/PDMR Shareholding
2nd Feb 20171:43 pmRNSDirector/PDMR Shareholding
1st Feb 20179:59 amRNSDirector/PDMR Shareholding
30th Jan 20176:17 pmRNSDirector/PDMR Shareholding
30th Jan 20177:00 amRNSDirector/PDMR Shareholding
26th Jan 20175:17 pmRNSDirector/PDMR Shareholding
26th Jan 20177:00 amRNSDirector/PDMR Shareholding
24th Jan 20173:59 pmRNSDirector/PDMR Shareholding
20th Jan 20175:38 pmRNSDirector/PDMR Shareholding
20th Jan 20177:01 amRNSDirector/PDMR Shareholding
20th Jan 20177:00 amRNSREPLACEMENT - Holding(s) in Company
18th Jan 20175:48 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.